Download PDF
Facial Plast Surg 2022; 38(02): 177-181
DOI: 10.1055/s-0042-1747970
Original Article

Exokine and the Youth-Boosting Treatment Based on One's Own Serum: Wheat and Chaff

Philippe Magistretti
1   Summit Clinic Crans Montana, Switzerland
,
Dario Bertossi
2   Department of Surgery, Dentistry, Paediatrics and Gynaecology and Head of Maxillofacial Plastic Surgery Unit, University of Verona, Italy
,
Ali Pirayesh
3   Amsterdam Plastic Surgery, Amsterdam, The Netherlands
,
Alessandra Magistretti
4   School of Medicine, University of Verona, Italy
,
Salvatore Chirumbolo 
5   Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Within the field of skin rejuvenation, clinicians have broadened the application of proven therapies toward antiaging medicine. Specifically, both platelet-rich plasma (PRP) and autologous-conditioned serum (ACS) have received great consideration among experts for novel indications. While the medical research focused on ACS is strengthened in their evidence and supported by promising outcomes, much more debates exist regarding the efficacy of PRP. Despite limited supporting literature to date, physicians and surgeons should be encouraged to explore the use of these approaches and in shedding further light on their potential benefits by contributing new evidence from basic and clinical scientific investigation.

Keywords

platelet-rich plasma - autologous serum - rejuvenation - PRP - aesthetic medicine

Authors' Contributions

D.B. and P.M. were involved in substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work. S.C. and D.B. were involved in drafting the work or revising it critically for important intellectual content. P.M., D.B., A.M., A.P., and S.C. gave final approval of the version to be published. P.M., D.B., A.M., A.P., and S.C. agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.




Publication History

Article published online:
22 April 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Atiyeh B, Oneisi A, Ghieh F. Platelet-rich plasma facial rejuvenation: myth or reality?. Aesthetic Plast Surg 2021; 45 (06) 2928-2938
    CrossrefPubMedGoogle Scholar
  • 2 Creaney L. Platelet-rich plasma and the biological complexity of tissue regeneration. Br J Sports Med 2011; 45 (08) 611
    CrossrefPubMedGoogle Scholar
  • 3 Mei-Dan O, Mann G, Maffulli N. Platelet-rich plasma: any substance into it?. Br J Sports Med 2010; 44 (09) 618-619
    CrossrefPubMedGoogle Scholar
  • 4 Lei X, Xu P, Cheng B. Problems and solutions for platelet-rich plasma in facial rejuvenation: a systematic review. Aesthetic Plast Surg 2019; 43 (02) 457-469
    CrossrefPubMedGoogle Scholar
  • 5 Samadi P, Sheykhhasan M, Khoshinani HM. The use of platelet-rich plasma in aesthetic and regenerative medicine: a comprehensive review. Aesthetic Plast Surg 2019; 43 (03) 803-814
    CrossrefPubMedGoogle Scholar
  • 6 Willemsen JC, van der Lei B, Vermeulen KM, Stevens HP. The effects of platelet-rich plasma on recovery time and aesthetic outcome in facial rejuvenation: preliminary retrospective observations. Aesthetic Plast Surg 2014; 38 (05) 1057-1063
    CrossrefPubMedGoogle Scholar
  • 7 Kenworthy W, Langridge B, Patel N, Waterhouse N. Use of platelet preparations in facial rejuvenation and wound healing remains unproven. Aesthetic Plast Surg 2016; 40 (02) 329-330
    CrossrefPubMedGoogle Scholar
  • 8 Psychogios N, Hau DD, Peng J. et al. The human serum metabolome. PLoS One 2011; 6 (02) e16957
    CrossrefPubMedGoogle Scholar
  • 9 Lawton KA, Berger A, Mitchell M. et al. Analysis of the adult human plasma metabolome. Pharmacogenomics 2008; 9 (04) 383-397
    CrossrefPubMedGoogle Scholar
  • 10 Rhee EP, Yang Q, Yu B. et al. An exome array study of the plasma metabolome. Nat Commun 2016; 7: 12360
    CrossrefPubMedGoogle Scholar
  • 11 Banihashemi M, Zabolinejad N, Salehi M, Hamidi Alamdari D, Nakhaizadeh S. Platelet-rich plasma use for facial rejuvenation: a clinical trial and review of current literature. Acta Biomed 2021; 92 (02) e2021187
    PubMedGoogle Scholar
  • 12 Mehryan P, Zartab H, Rajabi A, Pazhoohi N, Firooz A. Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles. J Cosmet Dermatol 2014; 13 (01) 72-78
    CrossrefPubMedGoogle Scholar
  • 13 Kassir M, Kroumpouzos G, Puja P. et al. Update in minimally invasive periorbital rejuvenation with a focus on platelet-rich plasma: a narrative review. J Cosmet Dermatol 2020; 19 (05) 1057-1062
    CrossrefPubMedGoogle Scholar
  • 14 Nazaroff J, Oyadomari S, Brown N, Wang D. Reporting in clinical studies on platelet-rich plasma therapy among all medical specialties: a systematic review of Level I and II studies. PLoS One 2021; 16 (04) e0250007
    CrossrefPubMedGoogle Scholar
  • 15 Pavlovic V, Ciric M, Jovanovic V, Stojanovic P. Platelet rich plasma: a short overview of certain bioactive components. Open Med (Wars) 2016; 11 (01) 242-247
    CrossrefPubMedGoogle Scholar
  • 16 Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy 2012; 28 (03) 429-439
    Google Scholar
  • 17 Lubkowska A, Dolegowska B, Banfi G. Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents 2012; 26 (2, Suppl 1): 3S-22S
    PubMedGoogle Scholar
  • 18 Kobayashi E, Flückiger L, Fujioka-Kobayashi M. et al. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig 2016; 20 (09) 2353-2360
    CrossrefPubMedGoogle Scholar
  • 19 Rui S, Yuan Y, Du C. et al. Comparison and investigation of exosomes derived from platelet-rich plasma activated by different agonists. Cell Transplant 2021; 30: 9636897211017833
    PubMedGoogle Scholar
  • 20 Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58: 575-606
    CrossrefPubMedGoogle Scholar
  • 21 Wilkie AO, Patey SJ, Kan SH, van den Ouweland AM, Hamel BC. FGFs, their receptors, and human limb malformations: clinical and molecular correlations. Am J Med Genet 2002; 112 (03) 266-278
    CrossrefPubMedGoogle Scholar
  • 22 Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992; 59: 115-165
    CrossrefPubMedGoogle Scholar
  • 23 Mossahebi-Mohammadi M, Quan M, Zhang JS, Li X. FGF signaling pathway: a key regulator of stem cell pluripotency. Front Cell Dev Biol 2020; 8: 79
    CrossrefPubMedGoogle Scholar
  • 24 Nunes QM, Li Y, Sun C, Kinnunen TK, Fernig DG. Fibroblast growth factors as tissue repair and regeneration therapeutics. PeerJ 2016; 4: e1535
    CrossrefPubMedGoogle Scholar
  • 25 Anitua E, Muruzabal F, Tayebba A. et al. Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Acta Ophthalmol 2015; 93 (08) e605-e614
    CrossrefPubMedGoogle Scholar
  • 26 Bausset O, Giraudo L, Veran J. et al. Formulation and storage of platelet-rich plasma homemade product. Biores Open Access 2012; 1 (03) 115-123
    CrossrefPubMedGoogle Scholar
  • 27 Lee JW, Kwon OH, Kim TK. et al. Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch Plast Surg 2013; 40 (05) 530-535
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Zhang M, Jiang F, Zhang X. et al. The effects of platelet-derived growth factor-BB on human dental pulp stem cells mediated dentin-pulp complex regeneration. Stem Cells Transl Med 2017; 6 (12) 2126-2134
    CrossrefPubMedGoogle Scholar
  • 29 Zhang M, Yu W, Niibe K. et al. The effects of platelet-derived growth factor-bb on bone marrow stromal cell-mediated vascularized bone regeneration. Stem Cells Int 2018; 2018: 3272098
    CrossrefPubMedGoogle Scholar
  • 30 Rajkumar VS, Shiwen X, Bostrom M. et al. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol 2006; 169 (06) 2254-2265
    CrossrefPubMedGoogle Scholar
  • 31 Rangarajan V, Dreher F. Topical growth factors for skin rejuvenation. In: Farage MA, Miller KW, Maibach HI. eds. Textbook of Aging Skin. Berlin, Heidelberg: Springer; DOI: 10.1007/978-3-540-89656-2_100
    CrossrefGoogle Scholar
  • 32 Dos Santos RG, Santos GS, Alkass N. et al. The regenerative mechanisms of platelet-rich plasma: a review. Cytokine 2021; 144: 155560
    CrossrefPubMedGoogle Scholar
  • 33 Wagner RJ, Zach KN. Platelet-rich plasma injection for quadriceps tendinopathy: a case report. WMJ 2021; 120 (01) 78-81
    PubMedGoogle Scholar
  • 34 Liu X, Zhang R, Zhu B. et al. Effects of leukocyte- and platelet-rich plasma on tendon disorders based on in vitro and in vivo studies (Review). Exp Ther Med 2021; 21 (06) 639
    CrossrefPubMedGoogle Scholar
  • 35 Wu Y, Kanna MS, Liu C, Zhou Y, Chan CK. Generation of autologous platelet-rich plasma by the ultrasonic standing waves. IEEE Trans Biomed Eng 2016; 63 (08) 1642-1652
    CrossrefPubMedGoogle Scholar
  • 36 Kushida S, Kakudo N, Morimoto N. et al. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs 2014; 17 (02) 186-192
    CrossrefPubMedGoogle Scholar
  • 37 Rutgers M, Saris DB, Dhert WJ, Creemers LB. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection. Arthritis Res Ther 2010; 12 (03) R114
    CrossrefPubMedGoogle Scholar
  • 38 von Wehren L, Pokorny K, Blanke F, Sailer J, Majewski M. Injection with autologous conditioned serum has better clinical results than eccentric training for chronic Achilles tendinopathy. Knee Surg Sports Traumatol Arthrosc 2019; 27 (09) 2744-2753
    CrossrefPubMedGoogle Scholar
  • 39 Geburek F, Lietzau M, Beineke A, Rohn K, Stadler PM. Effect of a single injection of autologous conditioned serum (ACS) on tendon healing in equine naturally occurring tendinopathies. Stem Cell Res Ther 2015; 6 (01) 126
    CrossrefPubMedGoogle Scholar
  • 40 Blázquez R, Sánchez-Margallo FM, Reinecke J. et al. Conditioned serum enhances the chondrogenic and immunomodulatory behavior of mesenchymal stem cells. Front Pharmacol 2019; 10: 699
    CrossrefPubMedGoogle Scholar
  • 41 Wehling P, Moser C, Frisbie D. et al. Autologous conditioned serum in the treatment of orthopedic diseases: the orthokine therapy. BioDrugs 2007; 21 (05) 323-332
    CrossrefPubMedGoogle Scholar
  • 42 Hraha TH, Doremus KM, McIlwraith CW, Frisbie DD. Autologous conditioned serum: the comparative cytokine profiles of two commercial methods (IRAP and IRAP II) using equine blood. Equine Vet J 2011; 43 (05) 516-521
    CrossrefPubMedGoogle Scholar
  • 43 Sawyere DM, Lanz OI, Dahlgren LA, Barry SL, Nichols AC, Werre SR. Cytokine and growth factor concentrations in canine autologous conditioned serum. Vet Surg 2016; 45 (05) 582-586
    CrossrefPubMedGoogle Scholar
  • 44 Heisterbach PE, Todorov A, Flückiger R, Evans CH, Majewski M. Effect of BMP-12, TGF-β1 and autologous conditioned serum on growth factor expression in Achilles tendon healing. Knee Surg Sports Traumatol Arthrosc 2012; 20 (10) 1907-1914
    CrossrefPubMedGoogle Scholar
  • 45 Majewski M, Ochsner PE, Liu F, Flückiger R, Evans CH. Accelerated healing of the rat Achilles tendon in response to autologous conditioned serum. Am J Sports Med 2009; 37 (11) 2117-2125
    CrossrefPubMedGoogle Scholar
  • 46 Shirokova L, Noskov S, Gorokhova V, Reinecke J, Shirokova K. Intra-articular injections of a whole blood clot secretome, autologous conditioned serum, have superior clinical and biochemical efficacy over platelet-rich plasma and induce rejuvenation-associated changes of joint metabolism: a prospective, controlled open-label clinical study in chronic knee osteoarthritis. Rejuvenation Res 2020; 23 (05) 401-410
    CrossrefPubMedGoogle Scholar
  • 47 Wright-Carpenter T, Klein P, Schäferhoff P, Appell HJ, Mir LM, Wehling P. Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med 2004; 25 (08) 588-593
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Pinto H, Garrido LG. Study to evaluate the aesthetic clinical impact of an autologous antiaging serum. J Drugs Dermatol 2013; 12 (03) 322-326
    PubMedGoogle Scholar
  • 49 Gold MH, Goldman MP, Biron J. Human growth factor and cytokine skin cream for facial skin rejuvenation as assessed by 3D in vivo optical skin imaging. J Drugs Dermatol 2007; 6 (10) 1018-1023
    PubMedGoogle Scholar
  • 50 Gold MH, Goldman MP, Biron J. Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation. J Drugs Dermatol 2007; 6 (02) 197-201
    PubMedGoogle Scholar
  • 51 Malerich S, Berson D. Next generation cosmeceuticals: the latest in peptides, growth factors, cytokines, and stem cells. Dermatol Clin 2014; 32 (01) 13-21
    CrossrefPubMedGoogle Scholar
  • 52 Kerscher M. Cell-free autologous conditioned serum (ACS) improved skin elasticity: results of an investigator initiated clinical trial. Orthoskin I JADD 2017; 76 (06) ) Suppl 1: AB63
    PubMedGoogle Scholar
  • 53 Magalon J, Bausset O, Veran J. et al. Physico-chemical factors influencing autologous conditioned serum purification. Biores Open Access 2014; 3 (01) 35-38
    CrossrefPubMedGoogle Scholar